Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
for Marginal Zone Lymphoma
Sites in Miami +3 more locations
Sponsor: University of Miami
Sex: All·Age: 18+
Code: NCT05296070·Phase 2·Recruiting·Listed Mar 2022